Corporate Updates

Sun Pharma hits record high

Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by 2 percent.

Sun Pharma stock surged 2 percent to Rs 707, while Ranbaxy Laboratories gained 2 percent to Rs 534.

USFDA has granted approval to Ranbaxy’s subsidiary Ohm Laboratories to manufacture and sell generic Diovan in the US.

Source: IIFL

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Most Popular

To Top